February 15, 2024
Federal regulators have issued a request for information to better understand the generic drug shortages that have posed challenges in health care.
This week, the Federal Trade Commission (FTC) and the U.S. Department of Health and Human Services (HHS) issued a joint request to learn more about how group purchasing organizations (GPO) and drug wholesalers may be contributing to generic drug shortages.
The request comes after the U.S. Senate Finance Committee published a white paper last month about potential policy approaches to address the issue.
“For years Americans have faced acute shortages of critical drugs, from chemotherapy to antibiotics, endangering patients,” FTC Chair Lina M. Khan said in a statement. “Our inquiry requests information on the factors driving these shortages and scrutinizes the practices of opaque drug middlemen.”
Here’s what you need to know:
HAP continues to monitor the latest on the nation’s drug shortages and provide updates to members. The request for information is available online.
Tags: Access to Care | Public Health | Regulatory Advocacy | Affordable Prescription Drugs
Click on topic below for category-specific news articles.
Related Links